Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. reduced its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 248,636 shares of the company’s stock after selling 11,842 shares during the period. Principal Financial Group Inc. owned approximately 0.50% of Prestige Consumer Healthcare worth $17,927,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. US Bancorp DE lifted its position in Prestige Consumer Healthcare by 20.3% during the third quarter. US Bancorp DE now owns 3,978 shares of the company’s stock valued at $287,000 after buying an additional 672 shares in the last quarter. Congress Asset Management Co. raised its stake in shares of Prestige Consumer Healthcare by 7.8% in the 3rd quarter. Congress Asset Management Co. now owns 865,123 shares of the company’s stock valued at $62,375,000 after acquiring an additional 62,411 shares during the period. Diversify Wealth Management LLC lifted its holdings in shares of Prestige Consumer Healthcare by 9.2% during the 3rd quarter. Diversify Wealth Management LLC now owns 7,686 shares of the company’s stock valued at $555,000 after acquiring an additional 646 shares in the last quarter. Pinnacle Associates Ltd. lifted its holdings in shares of Prestige Consumer Healthcare by 60.3% during the 3rd quarter. Pinnacle Associates Ltd. now owns 24,630 shares of the company’s stock valued at $1,776,000 after acquiring an additional 9,269 shares in the last quarter. Finally, First Trust Direct Indexing L.P. boosted its position in Prestige Consumer Healthcare by 5.7% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 5,016 shares of the company’s stock worth $362,000 after purchasing an additional 272 shares during the period. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Insider Activity at Prestige Consumer Healthcare

In related news, SVP Mary Beth Fritz sold 9,885 shares of Prestige Consumer Healthcare stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $81.97, for a total value of $810,273.45. Following the completion of the transaction, the senior vice president now directly owns 18,835 shares in the company, valued at approximately $1,543,904.95. This trade represents a 34.42 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider William P’pool sold 8,987 shares of the business’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $81.85, for a total value of $735,585.95. Following the completion of the sale, the insider now directly owns 20,058 shares of the company’s stock, valued at approximately $1,641,747.30. This represents a 30.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 27,935 shares of company stock valued at $2,289,025 over the last ninety days. Corporate insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Stock Up 0.6 %

Shares of Prestige Consumer Healthcare stock opened at $82.81 on Friday. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.56 and a quick ratio of 2.10. Prestige Consumer Healthcare Inc. has a 1-year low of $56.61 and a 1-year high of $83.83. The business has a 50-day moving average of $72.98 and a 200-day moving average of $70.09. The company has a market capitalization of $4.09 billion, a PE ratio of 20.05, a P/E/G ratio of 2.30 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.09. The company had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. Prestige Consumer Healthcare’s revenue for the quarter was down .9% compared to the same quarter last year. During the same period in the previous year, the business earned $1.07 EPS. As a group, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.45 EPS for the current fiscal year.

Wall Street Analyst Weigh In

PBH has been the topic of a number of recent research reports. DA Davidson restated a “buy” rating and set a $95.00 price objective on shares of Prestige Consumer Healthcare in a research note on Monday. Jefferies Financial Group reiterated a “hold” rating and set a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $94.20.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.